Claudia Palena

Also affiliated with National Cancer Institute, Center for Cancer Research

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication”.

Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication

Journal of Clinical Investigation(2022)10.1172/jci155148

N/A

2.9DataRank · unranked

119 citations

Paul L. Chariou, Sofia R. Gameiro, Haiyan Qin, Masafumi Iida, Kristen Fousek +7 more

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003238

N/A

1.2DataRank · unranked

41 citations

Katherine Lee-Wisdom, Renee N. Donahue, Ravi A. Madan, Fatima Karzai, Angie Schwab +16 more

Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007386

N/A

0.402DataRank · unranked

9 citations

Kristen Fousek, Lucas A. Horn, Shantel Angstadt, Haiyan Qin, Duane H. Hamilton +3 more

Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000326

N/A

0DataRank · unranked

97 citations

Jeffrey Riskin, Heidi Hempel, Kristen Fousek, Hanne Lind, Duane H. Hamilton +7 more

The Use of a Humanized NSG-β2m−/− Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa

Frontiers in Oncology(2020)10.3389/fonc.2020.00549

N/A

0DataRank · unranked

27 citations

Claire Smalley, Samuel T. Pellom, Ariana Sabzevari, Nicholas Roller, Lucas A. Horn +5 more

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer

Frontiers in Oncology(2021)10.3389/fonc.2020.581801

N/A

0DataRank · unranked

22 citations

Sofia R. Gameiro, Yohei Ozawa, Karin M. Knudson, Kristin C. Hicks, Claudia Palena +10 more

T Cell–Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0620

N/A

0DataRank · unranked

18 citations

Nicholas P. Schaub, Theresa M. Guerin, Tashinga E. Bapiro, Frances M. Richards, Vicky Chen +17 more

A rare insight into the immunosuppressive landscape of prostate cancer bone metastases

Cancer Cell(2021)10.1016/j.ccell.2021.09.004

N/A

0DataRank · unranked

9 citations

James L. Gulley, Claudia Palena

A phase 1 open label trial of intravenous administration of MVA-BN-Brachyury vaccine in patients with advanced cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2617

N/A

0DataRank · unranked

0 citations

Katherine Lee-Wisdom, Ravi A. Madan, Fatima Karzai, Renee N. Donahue, Claudia Palena +14 more

727 Resistance to enzalutamide and abiraterone drives tumor phenotypic plasticity and resistance to immune-mediated cytotoxicity

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.727

N/A

0DataRank · unranked

0 citations

Kristen Fousek, Lucas A. Horn, Haiyan Qin, Jeffrey Schlom, Claudia Palena +1 more

Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004561

N/A

0DataRank · unranked

48 citations

Paul L. Chariou, Lucas A. Horn, Kristin C. Hicks, Claudia Palena, Jeffrey Schlom +2 more

An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.11.008

N/A

0DataRank · unranked

24 citations

Lucas A. Horn, Haiyan Qin, Madeline Dahut, Masafumi Iida, Dan Yacubovich +5 more

Data from Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

(2023)10.1158/1078-0432.c.6517102.v1

N/A

0DataRank · unranked

0 citations

Philip M. Arlen, Kwong-Yok Tsang, Junko Yokokawa, Claudia Palena, Diane J. Poole +11 more

Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009595

N/A

0DataRank · unranked

5 citations

Renee N. Donahue, Claudia Palena, Sofia R. Gameiro, James W. Hodge, Duane H. Hamilton +2 more

Tumor Plasticity and Resistance to Immunotherapy

Trends in cancer(2020)10.1016/j.trecan.2020.02.001

N/A

0DataRank · unranked

145 citations

Kristen Fousek, Claudia Palena, Lucas A. Horn

Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-011378

N/A

0DataRank · unranked

7 citations

Maria Gracia-Hernandez, Loc Le, Masafumi Iida, James L. Gulley, Renee N. Donahue +4 more

Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression

Pharmacology & Therapeutics(2020)10.1016/j.pharmthera.2020.107692

N/A

0DataRank · unranked

359 citations

Lucas A. Horn, Claudia Palena, Kristen Fousek

Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000433

N/A

0DataRank · unranked

247 citations

Sofia R. Gameiro, Caroline Jochéms, Renee N. Donahue, Julius Strauss, James L. Gulley +3 more